| |
| |
|
| Insider
Information: |
Atlas Venture Associates Vi, L.p. |
| Relationship: |
10% Owner |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,813,217 |
|
|
Indirect Shares
|
3,808,547 |
|
|
| Direct
Value |
$88,451,697 |
|
|
|
Indirect Value
|
$110,977,278 |
|
|
| Total
Shares |
5,621,764 |
|
|
| Total
Value |
$199,428,975 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
10% Owner |
2005-08-03 |
1,473,598 |
2004-06-21 |
73,201 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
2006-02-24 |
13,095 |
2006-02-24 |
747,580 |
Premium* |
|
|
Helicos Biosciences Corp |
HLCSQ |
10% Owner |
2007-05-30 |
0 |
2007-05-30 |
2,987,766 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
10% Owner |
2011-07-28 |
326,524 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
10% Owner |
– – • |
2011-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
326,524 |
|
- |
|
| HLCSQ |
Helicos Biosciences Corp |
10% Owner |
– – • |
2007-05-30 |
4 |
B |
$9.00 |
$2,999,997 |
I/I |
333,333 |
2,987,766 |
1.5 |
- |
|
| HLCSQ |
Helicos Biosciences Corp |
10% Owner |
– – • |
2007-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,654,433 |
2,654,433 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2006-02-24 |
4 |
S |
$14.80 |
$887,820 |
I/I |
(60,000) |
747,580 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2006-02-24 |
4 |
S |
$14.80 |
$887,820 |
D/D |
(60,000) |
13,095 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2006-02-23 |
4 |
S |
$15.14 |
$476,960 |
I/I |
(31,500) |
0 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2006-02-23 |
4 |
S |
$15.14 |
$476,960 |
D/D |
(31,500) |
0 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2005-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,337,462) |
802,480 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
10% Owner |
– – • |
2005-08-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,165,620) |
1,473,598 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
10% Owner |
– – • |
2004-06-21 |
4 |
B |
$6.50 |
$1,586,000 |
I/I |
244,000 |
73,201 |
1.5 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2004-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,783,692 |
1,203,716 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2004-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,783,692 |
21,084 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2004-06-01 |
4 |
B |
$6.00 |
$766,602 |
D/D |
127,767 |
127,767 |
2.45 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2004-05-27 |
4/A |
B |
$6.00 |
$1,335,000 |
D/D |
222,500 |
2,331 |
2.45 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2004-05-27 |
4 |
B |
$6.00 |
$1,335,000 |
I/I |
222,500 |
133,501 |
1.5 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2004-05-27 |
4 |
B |
$6.00 |
$568,398 |
D/D |
94,733 |
2,340 |
2.45 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
